eIF3a was highly expressed in the peripheral blood of CRC patients (p < 0.01, log FC = 3.03) (Figure 1a) as well as in patient tumor tissues (Figure 1b) and CRC cell lines (Figure 1c). The gene discussed is EIF3A; the disease is neoplasm.